Oncolytic Adenovirus with MUC16-BiTE Shows Enhanced Antitumor Immune Response by Reversing the Tumor Microenvironment in PDX Model of Ovarian Cancer

Investigators tested the hypothesis that bispecific T cell engagers could activate and redirect cytotoxic T lymphocytes to increase the anti-tumor effect of oncolytic adenoviruses.